Patient Deaths Prompt the FDA to Suspend Three of Merck & Co.'s Keytruda Trials

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"Patient Deaths Prompt the FDA to Suspend Three of Merck's Keytruda Trials" ALT"Patient Deaths Prompt the FDA to Suspend Three of Merck's Keytruda Trials"July 6, 2017By Alex Keown,…

Continue ReadingPatient Deaths Prompt the FDA to Suspend Three of Merck & Co.'s Keytruda Trials

Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug" ALT"Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug"July…

Continue ReadingBay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug

Bristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-bristol-myers-squibb.jpg" NAME"Bristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial" ALT"Bristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial"July 5, 2017By Mark Terry, BioSpace.com Breaking News... Source: BioSpace

Continue ReadingBristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial